ArticleDiscover oncology2026

Integrating single-cell and spatial transcriptomics with pan-cancer bulk sequencing identifies OSR2 as a multifaceted biomarker for prognosis and tumor immunity.

Zhihui Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.